Table 2.
Baseline comparison between patients with different albumin-bilirubin grades
| Variable | ALBI ≤ -1.48 (n = 173) | ALBI > -1.48 (n = 85) | P-value |
| Demographic feature | |||
| Age (yr) | 47 (39-55) | 47 (38-56) | 0.926 |
| Male (Y/N) | 138/35 | 68/17 | 0.965 |
| Coexisting condition | |||
| Smoking (Y/N) | 52/121 | 26/59 | 0.931 |
| Drinking (Y/N) | 26/147 | 18/67 | 0.217 |
| Hypertension (Y/N) | 13/160 | 6/79 | 0.895 |
| Diabetes (Y/N) | 15/158 | 12/73 | 0.179 |
| Etiology | 0.025 | ||
| HCC (Y/N) | 71/102 | 16/69 | < 0.001 |
| Viral hepatitis | 143 | 57 | |
| Alcoholic cirrhosis | 4 | 4 | |
| PBC and AIH | 9 | 12 | |
| Other | 17 | 12 | |
| Hepatic feature | |||
| MELD score | 14 (10-18) | 23 (17.5-28) | < 0.001 |
| Child grade A/B/C | 42/80/51 | 1/14/70 | < 0.001 |
| Preoperative laboratory value | |||
| RBC (1012/L) | 3.40 (2.90-4.15) | 2.94 (2.49-3.32) | < 0.001 |
| HGB (g/L) | 105.0 (88.0-130.0) | 95.00 (86.5-107.0) | 0.001 |
| PLT (109/L) | 59.0 (38.5-103.0) | 45.0 (28.5-72.5) | 0.002 |
| WBC (109/L) | 3.71 (2.55-5.36) | 4.31 (2.84-7.38) | 0.084 |
| NEUT (109/L) | 2.33 (1.67-3.74) | 2.86 (1.80-5.90) | 0.044 |
| LYMPH (109/L) | 0.70 (0.45-1.15) | 0.60 (0.41-0.95) | 0.189 |
| MONO (109/L) | 0.28 (0.18-0.45) | 0.38 (0.22-0.57) | 0.011 |
| AFP (μg/L) | 4.74 (2.73-16.30) | 3.50 (2.22-6.23) | 0.032 |
| ALT (U/L) | 32.00 (22.00-47.00) | 38.00 (23.57-67.06) | 0.042 |
| AST (U/L) | 41.50 (29.00-59.00) | 54.52 (34.05-102.00) | 0.001 |
| TBIL (μmol/L) | 32.75 (17.67-54.83) | 105.48 (51.72-314.33) | < 0.001 |
| DBIL (μmol/L) | 11.70 (5.87-27.00) | 50.70 (19.70-192.23) | < 0.001 |
| ALB (g/L) | 37.20 (34.50-41.99) | 29.83 (26.95-32.11) | < 0.001 |
| BUN (mmol/L) | 4.39 (3.59-6.21) | 5.07 (3.87-7.32) | 0.077 |
| CRE (μmol/L) | 58.00 (48.00-68.85) | 61.88 (48.15-82.00) | 0.199 |
| GLU (mmol/L) | 5.60 (4.91-6.91) | 6.06 (5.03-8.40) | 0.062 |
| PT (s) | 17.20 (15.05-19.15) | 20.70 (18.05-24.30) | < 0.001 |
| APTT (s) | 42.40 (39.15-47.70) | 49.10 (43.25-54.75) | < 0.001 |
| INR | 1.41 (1.20-1.60) | 1.74 (1.49-2.27) | < 0.001 |
ALBI: Albumin-bilirubin; MELD: Model for end stage liver disease; HCC: Hepatocellular carcinoma; PBC: Primary biliary cirrhosis; AIH: Autoimmune hepatitis; RBC: Red blood cells; HGB: Hemoglobin; PLT: Platelets; WBC: White blood cells; NEUT: Neutrophil granulocytes; LYMPH: Lymphocytes; MONO: Monocytes; AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase; AST: Aspartate transaminase; TBIL: Total bilirubin; DBIL: Direct bilirubin; ALB: Albumin; BUN: Blood urea nitrogen; CRE: Creatinine; GLU: Glucose; PT: Prothrombin time; APTT: Activated partial thromboplastin time; INR: International normalized ratio.